| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.07 |